EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner

Wei Zhang iD, Yi Song, Changkun Li, Yuanyuan Luo, Mingwei Shao, Feng Guo, Fangyi Wei, Xunjie Fan, Wenwen Guo, Fengmei Xu, Yanhong Sang, Dongming Zhang und 21 weitere

Advanced Science · 2026-08 · 13 (47)

DOI: 10.1002/advs.202517222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.05.2026. Verfasst von Wei Zhang und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Canagliflozin, Gastrointestinal Microbiome, Kidney Glomerulus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Henan Province, Natural Science Foundation of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Canagliflozin reduces albuminuria in patients with diabetic kidney disease (DKD) beyond its glucose‐lowering effect, but the mechanisms remain unclear. We analyzed 85 patients treated with canagliflozin and 85 controls over 26 weeks to explore whether the gut microbiome and its metabolites contribute to renoprotection. Canagliflozin remodeled the gut microbiota, notably enriching Roseburia intestinalis and increasing plasma melibiose levels. In mice, canagliflozin alleviated glomerular endothelial injury and albuminuria. Similar effects were replicated by fecal microbiota transplantation, Roseburia intestinalis , or melibiose administration. Mechanistically, melibiose bound to and activated glyoxalase 1, reduced methylglyoxal, and suppressed the AGE‐RAGE pathway, preserving glomerular endothelial integrity. Furthermore, oral melibiose precursor supplementation reduced albuminuria in patients with early‐stage DKD. These findings suggest the involvement of a gut‐kidney axis in the renoprotective effects of canagliflozin and indicate that melibiose may serve as a potential therapeutic strategy for DKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesCanagliflozinGastrointestinal MicrobiomeKidney GlomerulusHumansAnimalsMiceMaleFemale

Stichwörter der Autor:innen

canagliflozindiabetic kidney diseaseglomerular endothelial injuryglyoxalase 1gut‐kidney axismelibiose

Substanzen

Canagliflozin

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou, China.
  • Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Endocrinology and Metabolism, Hebi Coal Industry (Group) Co., Ltd, General Hospital, Hebi, China.
  • Department of Endocrinology and Metabolism, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Wei Zhang, Guijun Qin

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Henan Province
  • Natural Science Foundation of Henan Province
  • Henan Joint Construction Program
  • Science and Technology Research Project of Henan Province

Zitieren

APA

Zhang, W., Song, Y., Li, C., Luo, Y., Shao, M., Guo, F., Wei, F., Fan, X., Guo, W., Xu, F., Sang, Y., Zhang, D., Zhou, Y., Wang, L., Kang, Z., Yang, Y., Song, C., Liu, Y., Ma, X., …, & Qin, G. (2026). Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner. Advanced Science, 13(47). https://doi.org/10.1002/advs.202517222

Vancouver

Zhang W, Song Y, Li C, Luo Y, Shao M, Guo F, et al. Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner. Advanced Science. 2026;13(47). doi:10.1002/advs.202517222

BibTeX
@article{Zhang2026,
  author = {Zhang, Wei and Song, Yi and Li, Changkun and Luo, Yuanyuan and Shao, Mingwei and Guo, Feng and Wei, Fangyi and Fan, Xunjie and Guo, Wenwen and Xu, Fengmei and Sang, Yanhong and Zhang, Dongming and Zhou, Yanhong and Wang, Lianwei and Kang, Zhiqiang and Yang, Yingjun and Song, Chunhua and Liu, Yanxia and Ma, Xiaojun and Wang, Jiao and Li, Chong and Ma, Shengnan and Zhao, Lin and Qin, Zhi and Xing, Guolan and Zhao, Qiubo and Li, Jun and Song, Shumin and Zhao, Dan and Huang, Ting and Wang, Qingzhu and Zhao, Yanyan and Qin, Guijun},
  title = {Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {47},
  doi = {10.1002/advs.202517222}
}
Kostenlos starten →